Unitary Healthcare has been acquired by Axel Health
Axel Health Oy, headquartered in Finland, has acquired the Finnish software company Unitary Healthcare Oy.
Unitary Healthcare provides a patient logistics solution for public healthcare providers. Their solution manages the logistics for non-urgent patient transfers at the district level, including internal hospital transfers, health center transfers and sharing facilities between municipalities. It also integrates the transfer of things such as patient information.
Founded in 2008, Axel Health is the market leading patient flow management solution in the Nordics, with customers ranging from the largest university hospitals to smaller healthcare providers. The software solution offers patient self-check-in and guidance through the hospital visit, reducing patient queues and freeing up hospital resources as well as hospital operational planning. Its software is provided on a subscription basis. Axel Health is a portfolio company of Standout Capital.
In Finland, Axel Health is the market leader in its sector and continues to grow rapidly. The company’s goal is to be the leading healthcare management software provider in the Nordics, with the best end-to-end solutions to help healthcare organizations optimize their services, whether physical or virtual.
Oaklins’ team in Finland acted as the sell-side financial advisor in this transaction.
Talk to the deal team
Related deals
Bluegem Capital Partners and AREV Partners have acquired 100% of Groupe Pinard
Bluegem Capital Partners and AREV Partners have successfully completed the acquisition of the prestigious Groupe Pinard from IK Partners.
Learn moreLumiforte partners with Kartesia to propel global growth and innovation
Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.
Learn morePanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production
PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.
Learn more